Imagine a world where you could indulge in the sweet delights of sugar without the guilt of excess calories, tooth decay, or the looming threat of diabetes. Sounds too good to be true, right? But here's where it gets exciting: scientists at Tufts University have developed a groundbreaking method to produce a rare sugar called tagatose, which promises to deliver the sweetness of table sugar without its harmful side effects—and it might even offer some health benefits. And this is the part most people miss: it’s not just about cutting calories; it’s about reimagining how we sweeten our lives.
In a study published in Cell Reports Physical Science (https://www.cell.com/cell-reports-physical-science/fulltext/S2666-3864(25)00592-2), researchers unveiled a biosynthetic process to produce tagatose, a sugar that naturally occurs in minuscule amounts in dairy products like milk, yogurt, and cheese, as well as in trace levels in fruits like apples, pineapples, and oranges. Because it’s so rare—typically less than 0.2% of sugars in natural sources—it’s usually manufactured rather than extracted. But here’s the controversial part: traditional manufacturing methods are inefficient and costly, leaving tagatose out of reach for most consumers. Could this new method finally make it a viable sugar alternative for the masses?
Tufts researchers tackled this challenge by engineering Escherichia coli bacteria to act as tiny sugar factories. These bacteria are loaded with specific enzymes that convert abundant glucose into tagatose. The key innovation? A newly discovered enzyme from slime mold, galactose-1-phosphate-selective phosphatase (Gal1P), which helps produce galactose directly from glucose. A second enzyme, arabinose isomerase, completes the conversion to tagatose. This process boasts a staggering 95% yield—far surpassing conventional methods, which only achieve 40 to 77%.
Tagatose is 92% as sweet as sucrose but packs 60% fewer calories. It’s also been designated “generally recognized as safe” by the FDA, putting it in the same category as everyday ingredients like salt, vinegar, and baking soda. For diabetics, it’s a game-changer: it’s only partially absorbed in the small intestine, minimizing its impact on blood glucose and insulin levels. Clinical studies show minimal increases in plasma glucose or insulin after consumption. But here’s where it gets even more intriguing: unlike sucrose, which fuels cavity-causing bacteria, tagatose may actually reduce their growth and support healthy oral and gut bacteria.
What makes tagatose truly stand out is its versatility. It’s not just a sweetener—it’s a “bulk sweetener,” meaning it can replace sugar in both taste and texture, something high-intensity sweeteners can’t achieve. It even browns like table sugar during cooking, making it a chef’s dream. In taste tests, it’s the closest match to table sugar among all alternatives.
“The key innovation was finding the slime mold Gal1P enzyme and splicing it into our production bacteria,” explained Nik Nair (https://engineering.tufts.edu/chbe/people/faculty/nik-nair), associate professor of chemical and biological engineering at Tufts. “This allowed us to reverse a natural biological pathway, turning glucose into galactose and then tagatose. From here, we can potentially synthesize other rare sugars.”
But here’s the question that sparks debate: Will tagatose revolutionize the sugar industry, or will it remain a niche product due to lingering skepticism about artificial sweeteners? As this healthier sugar substitute moves closer to mainstream availability, one thing is clear: the way we sweeten our lives is on the brink of transformation. What do you think—is tagatose the future of sugar, or just another fad? Let’s discuss in the comments!
